Genome instability resulting from DNA repair defects is a primary cause of cancer. Chromatin plays a central role in coordinating nuclear processes, yet the genome maintenance functions of many chromatin-associated proteins remain poorly understood. KMT2D, a histone methyltransferase classically known for enhancer regulation, is frequently mutated in human cancers. Its loss results in limited transcriptional changes suggesting additional, unexplored pathogenic mechanisms. Preliminary data show that KMT2D loss sensitizes cells to genotoxic agents, increases DNA breaks and activates cellular checkpoints, while mass spectrometry identified a novel damage-dependent interaction with RPA. We hypothesize that KMT2D plays a direct, transcription-independent role at DNA damage sites. To explore this hypothesis, this study pursued two objectives: the establishment of a validated rescue platform in KMT2D KO cells and the development of an innovative AlphaFold3-based workflow to map the KMT2D-RPA1 interaction. KMT2D KO cells re-expressing full-length KMT2D showed a rescue trend, with reduced DNA damage under replication and genotoxic stress. The structural workflow identified a conserved KMT2D region that is predicted to interact with RPA1 with high-confidence, closely resembling the structure of known interactors. These findings establish a robust dual platform essential for dissecting KMT2D role in genome integrity maintenance, opening new therapeutic avenues.

Genome instability resulting from DNA repair defects is a primary cause of cancer. Chromatin plays a central role in coordinating nuclear processes, yet the genome maintenance functions of many chromatin-associated proteins remain poorly understood. KMT2D, a histone methyltransferase classically known for enhancer regulation, is frequently mutated in human cancers. Its loss results in limited transcriptional changes suggesting additional, unexplored pathogenic mechanisms. Preliminary data show that KMT2D loss sensitizes cells to genotoxic agents, increases DNA breaks and activates cellular checkpoints, while mass spectrometry identified a novel damage-dependent interaction with RPA. We hypothesize that KMT2D plays a direct, transcription-independent role at DNA damage sites. To explore this hypothesis, this study pursued two objectives: the establishment of a validated rescue platform in KMT2D KO cells and the development of an innovative AlphaFold3-based workflow to map the KMT2D-RPA1 interaction. KMT2D KO cells re-expressing full-length KMT2D showed a rescue trend, with reduced DNA damage under replication and genotoxic stress. The structural workflow identified a conserved KMT2D region that is predicted to interact with RPA1 with high-confidence, closely resembling the structure of known interactors. These findings establish a robust dual platform essential for dissecting KMT2D role in genome integrity maintenance, opening new therapeutic avenues.

Defining a Chromatin-Based Role for KMT2D in Replication Stress and Genome Integrity

BELLARTE, MATTEO
2025/2026

Abstract

Genome instability resulting from DNA repair defects is a primary cause of cancer. Chromatin plays a central role in coordinating nuclear processes, yet the genome maintenance functions of many chromatin-associated proteins remain poorly understood. KMT2D, a histone methyltransferase classically known for enhancer regulation, is frequently mutated in human cancers. Its loss results in limited transcriptional changes suggesting additional, unexplored pathogenic mechanisms. Preliminary data show that KMT2D loss sensitizes cells to genotoxic agents, increases DNA breaks and activates cellular checkpoints, while mass spectrometry identified a novel damage-dependent interaction with RPA. We hypothesize that KMT2D plays a direct, transcription-independent role at DNA damage sites. To explore this hypothesis, this study pursued two objectives: the establishment of a validated rescue platform in KMT2D KO cells and the development of an innovative AlphaFold3-based workflow to map the KMT2D-RPA1 interaction. KMT2D KO cells re-expressing full-length KMT2D showed a rescue trend, with reduced DNA damage under replication and genotoxic stress. The structural workflow identified a conserved KMT2D region that is predicted to interact with RPA1 with high-confidence, closely resembling the structure of known interactors. These findings establish a robust dual platform essential for dissecting KMT2D role in genome integrity maintenance, opening new therapeutic avenues.
2025
Defining a Chromatin-Based Role for KMT2D in Replication Stress and Genome Integrity
Genome instability resulting from DNA repair defects is a primary cause of cancer. Chromatin plays a central role in coordinating nuclear processes, yet the genome maintenance functions of many chromatin-associated proteins remain poorly understood. KMT2D, a histone methyltransferase classically known for enhancer regulation, is frequently mutated in human cancers. Its loss results in limited transcriptional changes suggesting additional, unexplored pathogenic mechanisms. Preliminary data show that KMT2D loss sensitizes cells to genotoxic agents, increases DNA breaks and activates cellular checkpoints, while mass spectrometry identified a novel damage-dependent interaction with RPA. We hypothesize that KMT2D plays a direct, transcription-independent role at DNA damage sites. To explore this hypothesis, this study pursued two objectives: the establishment of a validated rescue platform in KMT2D KO cells and the development of an innovative AlphaFold3-based workflow to map the KMT2D-RPA1 interaction. KMT2D KO cells re-expressing full-length KMT2D showed a rescue trend, with reduced DNA damage under replication and genotoxic stress. The structural workflow identified a conserved KMT2D region that is predicted to interact with RPA1 with high-confidence, closely resembling the structure of known interactors. These findings establish a robust dual platform essential for dissecting KMT2D role in genome integrity maintenance, opening new therapeutic avenues.
Genome Instability
Chromatin
Cancer
Epigenetics
Replication stress
File in questo prodotto:
File Dimensione Formato  
Bellarte_Matteo.pdf

Accesso riservato

Dimensione 1.12 MB
Formato Adobe PDF
1.12 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/114542